Acuta Capital Partners, LLC C4 Therapeutics, Inc. Transaction History

Acuta Capital Partners, LLC

  • $98.8 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$29.39 - $46.86 $617,190 - $984,060
-21,000 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
$35.91 - $50.5 $754,109 - $1.06 Million
21,000 New
21,000 $938,000
Q1 2021

May 17, 2021
SELL
$31.96 - $46.5 $3.52 Million - $5.12 Million
-110,000 Closed
0 $0
Q4 2020

Feb 16, 2021
BUY
$22.8 - $37.05 $2.51 Million - $4.08 Million
110,000 New
110,000 $3.64 Million

Others Institutions Holding CCCC

# of Institutions
130
Shares Held
63.5M
Call Options Held
670K
Put Options Held
54.8K
View Full List

About C4 Therapeutics, Inc.

CCCC Quotes by TradingView
  • Ticker CCCC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,913,800
  • Market Cap $178M
  • Description
  • C4 Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel therapeutic candidates to degrade disease-causing proteins for the treatment of cancer, neurodegenerative conditions, and other diseases. Its lead product candidate is CFT7455, an orally bioavailable MonoDAC degrader of protein that is in Phase 1/2 trial targeting ...
More about CCCC
Track This Portfolio

Track Acuta Capital Partners, LLC Portfolio

Follow Acuta Capital Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acuta Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acuta Capital Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email